This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Nicox S.a., Pfizer Corporation. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: **Innovative Contributions of Ganesh Prasanna in Ophthalmic Pharmaceutical Patents**
Introduction
Ganesh Prasanna is a notable inventor based in San Diego, California, recognized for his significant contributions to the field of ophthalmic pharmaceuticals. With a portfolio of two patents, his innovative work focuses on improving treatments for conditions like glaucoma and ocular hypertension.
Latest Patents
Among Ganesh Prasanna's latest inventions is the patent for "Nitric oxide donating prostamides," which describes nitroderivatives of prostaglandins that exhibit enhanced pharmacological activity and tolerability. This innovation presents a promising approach for the treatment of glaucoma and ocular hypertension. In addition, he has developed patents related to EP2 agonists, which detail methods for their preparation, along with pharmaceutical compositions incorporating these compounds and methods for effectively using them to lower intraocular pressure and treat glaucoma.
Career Highlights
Throughout his career, Ganesh Prasanna has made impactful strides while working with major pharmaceutical companies such as Nicox S.A. and Pfizer Corporation. His tenure at these organizations has allowed him to translate his innovative ideas into tangible products aimed at improving patient outcomes.
Collaborations
In his professional journey, Ganesh has collaborated with several esteemed individuals, including coworkers Francesca Benedini and Stefano Biondi. These partnerships have further enriched his research endeavors and have contributed to the development of his patented inventions.
Conclusion
Ganesh Prasanna exemplifies the spirit of innovation in the pharmaceutical industry. Through his patents and collaborations, he has made significant strides in the treatment of ocular conditions, demonstrating the potential for his inventions to impact the lives of patients suffering from glaucoma and ocular hypertension. His work stands as a testament to the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile